Abbott Diagnostics
VIRAL HEPATITIS IN THE CONTEXT OF NEW MOLECULAR INSIGHTS

Bracco
DIAGNOSTIC ROLE OF CONTRAST-ENHANCED ULTRASOUND IN 2006: GUIDELINES AND NEW POTENTIAL APPLICATIONS

GlaxoSmithKline
THE RISE OF HBeAg-NEGATIVE CHRONIC HEPATITIS B

Merz Pharmaceuticals
HEPATIC ENCEPHALOPATHY - DOES IT MATTER?

SciClone Pharmaceuticals, Inc
THERAPEUTIC STRATEGIES FOR LIVER DISEASE: HEPATITIS B, HEPATITIS C, HEPATOCELLULAR CARCINOMA TREATMENT REGIMENS USING THYMALFASIN, AN IMMUNE SYSTEM ENHANCER

Valeant Pharmaceuticals International
ANTI-HCV THERAPY: OPPORTUNITIES TO MAXIMIZE RESPONSE

Schering Plough Pharmaceuticals
ROADMAP TO IDEAL AND BEYOND

Friday, April 28, 2006

Gilead Sciences
CHRONIC HEPATITIS B: OVERCOMING A COMPLEX CLINICAL CHALLENGE

Roche
PERFECTING PERFORMANCE FOR OUR PATIENTS

Saturday, April 29, 2006

Idenix/Novartis
RAISING EXPECTATIONS FOR IMPROVED THERAPEUTIC OUTCOMES IN HEPATITIS B

Sunday, April 30, 2006

Bristol-Myers Squibb Company
EVIDENCE FOR ACTION; HOPE FOR HEPATITIS B